Jan Simpkins

Datos Biográficos

ID5542873
NOMBREJan Simpkins
NOMBRESJan
APELLIDOSimpkins
FIRMASIMPKINS J
AFILIACIONESKaiser Permanente
VERIFICADONo
TOTAL DE OBRAS4
TOTAL DE CITAS0
TOTAL COMO AUTOR4
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2005
AÑO MÁS RECIENTE DE PUBLICACIÓN2007
ÍNDICE H0

  • Academic Detailing to Improve Laboratory Testing Among Outpatient Medication Users

    Jennifer Elston Lafata, Margaret J Gunter et al.ARTICLEMedical Care2007Referencias: 27

    PURPOSE: To determine whether group academic detailing with performance feedback increases recommended laboratory monitoring among outpatients dispensed medications. METHODS: Thirty-eight primary care practices in 3 states were randomized to group academic detailing with physician-level performance feedback (intervention) or a control group. Adjusted differences in creatinine and potassium testing between intervention and control group patients w…

  • Use of Guideline Recommended Follow-Up Care in Cancer Survivors

    Gregory S Cooper, Christine Cole Johnson et al.ARTICLEMedical Care2006Referencias: 16

    BACKGROUND: After potentially curative cancer treatment, patients may receive procedures for routine monitoring for recurrence or for evaluation of symptoms or signs. OBJECTIVE: We sought to characterize surveillance care guideline-recommended and other procedures performed in cancer survivors according to routine versus diagnostic indications. METHODS: This was a retrospective cohort study of paper and electronic medical records between 1990 and…

  • Potential Drug–Drug Interactions in the Outpatient Setting

    Jennifer Elston Lafata, Lonni Schultz et al.ARTICLEMedical Care2006Referencias: 40

    BACKGROUND: Although medication safety research has tended to focus on inpatients, the safety of drug use among outpatients is also a concern. OBJECTIVE: We estimate the frequency of potentially interacting concomitant medication dispensing among outpatients. RESEARCH DESIGN: We report the number and percent of patients annually dispensed an object drug of interest (ie, warfarin, digoxin, cyclosporine, or lovastatin/simvastatin) with a potentiall…

  • Routine Surveillance Care After Cancer Treatment With Curative Intent

    Jennifer Elston Lafata, Jan Simpkins et al.ARTICLEMedical Care2005Referencias: 16

    BACKGROUND: Many consensus guidelines recommend routine surveillance to detect recurrent disease among cancer survivors. We compare surveillance care receipt to guideline recommendations. METHODS: Cohorts of patients aged 30 years or older diagnosed with breast, colorectal, endometrial, lung, or prostate cancer between 1990 and 1995 and treated with curative intent were identified (n = 100 per site). Receipt and indications for examinations and p…